Therapeutic options for regionally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Therapeutic options for regionally advanced non-small cell lung cancer

Published:1996-06 Issue:2-3 Volume:14 Page:281-300
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Buccheri Gianfranco,Ferrigno Domenico

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference85 articles.

1. Cancer Statistics;Boring;CA Cancer J Clin,1994

2. The impact of histological type and tumour localisation on the prognosis in 1000 resected lung cancer patients with special view to adenocarcinoma;Wilde;Pneumologie,1990

3. Survival in lung cancer. An analysis of the effects of age, sex, resectability, and histopathologic type;Rossing;Am Rev Respir Dis,1982

4. Cancer of the lung;Minna,1985

5. A new international staging system for lung cancer;Mountain;Chest,1986

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA ‐92b acts as an oncogene by targeting PTEN / AKT in NSCLC;Cell Biochemistry and Function;2020-07-06

2. Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I study;Journal of Cancer Research and Clinical Oncology;2012-03-10

3. Guidelines on the radical management of patients with lung cancer;Thorax;2010-10-01

4. Management of Unresectable Stage III Non–Small-Cell Lung Cancer with Combined-Modality Therapy: A Review of the Current Literature and Recommendations for Treatment;Clinical Lung Cancer;2008-03

5. A Phase III Study of Surgical Resection and Paclitaxel/Carboplatin Chemotherapy with or Without Adjuvant Radiation Therapy for Resected Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B 9734;Clinical Lung Cancer;2007-01